benzoxazoles has been researched along with Retinoblastoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fu, Y; Hu, T; Li, K; Li, Z; Song, J; Tang, L | 1 |
1 other study(ies) available for benzoxazoles and Retinoblastoma
Article | Year |
---|---|
mTOR inhibition by TAK-228 is effective against growth, survival and angiogenesis in preclinical retinoblastoma models.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Benzoxazoles; Cell Line, Tumor; Humans; Inhibitory Concentration 50; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neovascularization, Pathologic; Pyrimidines; Retinal Neoplasms; Retinoblastoma; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2022 |